Tissue-specific oxidative stress and loss of mitochondria in CoQ-deficient Pdss2 mutant mice

Catarina M Quinzii1, Caterina Garone, Valentina Emmanuele

  • 1Department of Neurology, Columbia University Medical Center, New York, New York 10032, USA.

Insights

Primary Coenzyme Q10 (CoQ10) deficiencies cause varied diseases. Severe PDSS2 mutations in mice lead to organ-specific mitochondrial loss and renal failure due to oxidative stress.

Area of Science:

  • Biochemistry
  • Genetics
  • Mitochondrial Biology

Background:

  • Primary Coenzyme Q10 (CoQ10) deficiencies are heterogeneous genetic disorders impacting CoQ10 biosynthesis.
  • Mutations in PDSS2, COQ2, and ADCK3 genes lead to distinct cellular phenotypes in CoQ10 deficiency.

Purpose of the Study:

  • To investigate the in vivo effects of Pdss2 deficiency in mice.
  • To determine the role of oxidative stress in organ-specific pathology of CoQ10 deficiency.

Main Methods:

  • Utilized a mouse model (CBA/Pdss2(kd/kd)) to study Pdss2 deficiency across disease stages.
  • Analyzed CoQ9 levels, mitochondrial respiratory chain activity, reactive oxygen species (ROS) production, oxidative damage markers, and mitochondrial mass (citrate synthase activity) in affected and unaffected organs.

Main Results:

  • Pdss2 mutant mice exhibited widespread CoQ9 deficiency and mitochondrial dysfunction.
  • Affected organs showed increased ROS production, oxidative stress, mitochondrial DNA depletion, and reduced mitochondrial mass.
  • Kidney-specific mitochondrial loss, driven by oxidative stress, was observed in Pdss2(kd/kd) mice.

Conclusions:

  • Severe CoQ10 deficiency due to PDSS2 mutations causes organ-specific mitochondrial dysfunction and failure.
  • Oxidative stress plays a critical role in the pathogenesis of renal failure in Pdss2(kd/kd) mice.
  • These findings highlight the complex interplay between CoQ10 levels, oxidative stress, and organ integrity in primary CoQ10 deficiencies.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Electron Transport Chain: Complex III and IV01:43

Electron Transport Chain: Complex III and IV

During the electron transport chain, electrons from NADH and FADH2 are first transferred to complexes I and II, respectively. These two complexes then transfer the electrons to ubiquinol, which carries them further to complex III. Complex III passes the electrons across the intermembrane space to Cyt c, which carries them further to complex IV. Complex IV donates electrons to oxygen and reduces it to water. As electrons pass through complexes I, III, and IV, the energy released aids the pumping...